CTCBIO Inc.

KOSDAQ:A060590 Stock Report

Market Cap: ₩77.9b

CTCBIO Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sun Cho Chang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.3yrs

Recent management updates

Recent updates

Analysis Article • Dec 02

These 4 Measures Indicate That CTCBIO (KOSDAQ:060590) Is Using Debt Reasonably Well

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Sep 29

Some Shareholders Feeling Restless Over CTCBIO Inc.'s (KOSDAQ:060590) P/S Ratio

It's not a stretch to say that CTCBIO Inc.'s ( KOSDAQ:060590 ) price-to-sales (or "P/S") ratio of 1x right now seems...
Analysis Article • Mar 15

CTCBIO's (KOSDAQ:060590) Shareholders Are Down 64% On Their Shares

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
Analysis Article • Jan 21

Is CTCBIO (KOSDAQ:060590) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Nov 29

Would Shareholders Who Purchased CTCBIO's (KOSDAQ:060590) Stock Five Years Be Happy With The Share price Today?

Statistically speaking, long term investing is a profitable endeavour. But that doesn't mean long term investors can...

CEO

Sun Cho Chang (63 yo)

2.3yrs
Tenure

Mr. Sun Cho Chang is CEO & Executive Director of CTCBIO Inc. from March 29, 2024.

Board Members

NamePositionTenureCompensationOwnership
Sun Cho Chang
CEO & Executive Director2.3yrsno datano data
Youngduk Kim
Independent Outside Director1.3yrsno datano data
Young-min Kim
Auditorno datano datano data
Junghoon Kim
Non-Executive Director4.3yrsno datano data
2.3yrs
Average Tenure
60.5yo
Average Age

Experienced Board: A060590's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 20:10
End of Day Share Price 2026/06/16 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CTCBIO Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
JongHoon LeeDaishin Securities Co. Ltd.
Al Eum LeeiM Securities
Jae Hoon ShinLS Securities Co., Ltd.